Tariffs and Structural Reforms in the Generics Industry

This chapter examines the influence of tariffs on the generics industry and their role in sparking discussions about essential structural reforms for improving access to affordable medications in the U.S. It underscores the significance of the patent landscape and competition to create a sustainable pharmaceutical market while highlighting optimism for future governmental dialogues addressing patient needs.